Journals / The Anatolian Journal of Cardiology / 2015 / Cilt: 15 - Sayı: 5

Yüksek platelet-lenfosit oranı ST-yükselmesiz akut koroner sendrom hastalarında sol ventrikül sistolik disfonksiyonunu öngörebilir mi?

Could elevated platelet-lymphocyte ratio predict left ventricular systolic dysfunction in patients with non-ST elevated acute coronary syndrome?

Pages
385–390
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

PLR >135.6 was found to be an independent predictor of systolic dysfunction in the multivariate analyses (?: 0.306, 95% confidence interval: 0.151-0.619; p=0.001).Conclusion: A high PLR is a strong and independent predictor for LVSD in patients with NST-ACS

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The prognostic value of a high platelet-lymphocyte ratio (PLR) has been reported in patients with non-ST elevated myocardial infarction (NSTEMI) and different oncologic disorders.
📊
Key Findings & Data:We aimed to evaluate the predictive value of the PLR for left ventricular systolic dysfunction (LVSD) in patients with non-ST elevated acute coronary syndrome (NST-ACS).Methods: A total of 220 patients with NST-ACS were included in the study.
💡
Conclusion & Impact:PLR >135.6 was found to be an independent predictor of systolic dysfunction in the multivariate analyses (?: 0.306, 95% confidence interval: 0.151-0.619; p=0.001).Conclusion: A high PLR is a strong and independent predictor for LVSD in patients with NST-ACS
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The prognostic value of a high platelet-lymphocyte ratio (PLR) has been reported in patients with non-ST elevated myocardial infarction (NSTEMI) and different oncologic disorders. We aimed to evaluate the predictive value of the PLR for left ventricular systolic dysfunction (LVSD) in patients with non-ST elevated acute coronary syndrome (NST-ACS).Methods: A total of 220 patients with NST-ACS were included in the study. The study population was divided into tertiles based on admission PLR values. High (n=73) and low PLR (n=147) groups were defined as patients having values in the third tertile (>135.6) and lower 2 tertiles (<=135.6), respectively. Left ventricular dysfunction was defined as ejection fraction <=40%, and related variables were evaluated by backward conditional binary logistic regression analysis.Results: The patients in the high PLR group were older (p<0.001) and had a higher rate of previous myocardial infarction and NSTEMI (p=0.046, p=0.013, respectively). There were significantly more coronary arteries narrowed (p=0.001) and lower left ventricular ejection fraction (p<0.001) in the high PLR group. Baseline platelet levels were significantly higher (p<0.001) and triglyceride and lymphocyte levels were significantly lower (p=0.009 and p<0.001, respectively) in the high PLR group. PLR >135.6 was found to be an independent predictor of systolic dysfunction in the multivariate analyses (?: 0.306, 95% confidence interval: 0.151-0.619; p=0.001).Conclusion: A high PLR is a strong and independent predictor for LVSD in patients with NST-ACS

Özet

Amaç: Yüksek platelet-lenfosit oranının (PLO) prognostik değeri ST yükselmesi olmayan miyokart enfarktüsünde (NSTEMI) ve çeşitli onkolojik hastalıklarda gösterilmiştir. Biz bu çalışmada ST yükselmesi olmayan akut koroner sendrom (NST-ACS) hastalarında PLO'nun sol ventrikül sistolik disfonksiyonunda (SVSD) öngördürücü değerini incelemeyi amaçladık. Yöntemler: Çalışmaya NST-ACS tanısı olan toplam 220 hasta alındı. Çalışma hastaları başvurudaki PLO değerlerine göre tersiyele ayrıldı. Yüksek (n=73) ve düşük PLO (n=147) gruplarındaki hastalar sırasıyla en yüksek grup (>135,6) ve düşük ( 135,6 olması sistolik disfonksiyonun bağımsız prediktörü olduğu bulundu (?: 0,306, %95 güvenli aralık: 0,151-0,619; p=0,001). Sonuç: Yüksek PLO, NST-ACS hastalarında SVSD için bağımsız ve güçlü prediktördür

🔖

Cite This Article

BEKLER, A., GAZİ, E., YILMAZ, M., TEMİZ, A., ALTUN, B., BARUTÇU, A., PEKER, T. (2015). Yüksek platelet-lenfosit oranı ST-yükselmesiz akut koroner sendrom hastalarında sol ventrikül sistolik disfonksiyonunu öngörebilir mi?. The Anatolian Journal of Cardiology, Cilt: 15 - Sayı: 5, 385–390. https://ajindex.com/articles/365623

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Køber L, Torp-Pedersen C, Jørgensen S, Eliasen P, Camm AJ. Changes in absolute and relative importance in the prognostic value of left ventricular systolic function and congestive heart failure after acute myocardial infarction. TRACE study group. Am J Cardiol 1998; 81: 1292-7. [CrossRef] 2. Hasdai D, Topol EJ, Kilaru R, Battler A, Harrington RA, Vahanian A, et al. Frequency, patient characteristics, and outcomes of mild-tomoderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials. Am Heart J 2003; 145: 73-9. [CrossRef] 3. Steg PG, Dabbous OH, Feldman LJ, Cohen-Solel A, Aumont MC, Lopez-Sendon J, et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observation from GRACE." Circulation 2004; 109: 494-9. [CrossRef] 4. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991; 84: 613-7. [CrossRef] 5. Iijima R, Ndrepepa G, Mehilli J, Bruskina O, Schulz S, Schomig A, et al. Relationship between platelet count and 30 day clinical outcomes after percutaneous coronary interventions. Pooled analysis of four ISAR trials. Thromb Haemost 2007; 98: 852-7. 6. Nikolsky E, Grines CL, Cox DA, Garcia E, Tcheng JE, Sadeghi M, et al. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). Am J Cardiol 2007; 99: 1055-61. [CrossRef] 7. Jakl M, Sevcik R, Ceral J, Fatorova I, Horacek JM, Vojacek J. Mean platelet volume and platelet count: overlooked markers of high ontreatment platelet reactivity and worse outcome in patients with acute coronary syndrome. Anadolu Kardiyol Derg 2014; 14: 85-6. 8. Ommen SR, Hammill SC, Gibbons RJ. The relative lymphocyte count predicts death in patients receiving implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2002; 25: 1424-8. [CrossRef] 9. Acanfora D, Gheorghiade M, Trojano L, Furgi G, Pasini E, Picone C, et al. Relative lymphocyte count: a prognostic indicator of mortality in elderly patients with congestive heart failure. Am Heart J 2001; 142: 167-73. [CrossRef] 10. Zouridakis EG, Garcia-Moll X, Kaski JC. Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. Am J Cardiol 2000; 86: 449-51. [CrossRef]